Related Experiment Video
Updated: Aug 14, 2026

Intra-Omental Islet Transplantation Using h-Omental Matrix Islet filliNG (hOMING)
Published on: March 14, 2019
[Personal insulin pumps--from experiment research till recommended method of diabetes treatment]
Michał Mozdzan1, Jan Ruxer, Jerzy Loba
1Klinika Diabetologii IMW Uniwersytetu Medycznego w Lodzi. mozdzanm@poczta.onet.pl
Abstract:
Diabetes treatment with continuous insulin infusion with the use of personal insulin pumps secures strict metabolic control in diabetes--patients and can minimize a number of complications of diabetes. According to American Diabetes Association (2001), diabetes therapy with continuous insulin infusion is recommended for each person, who accept this therapy method. Personal insulin pump is well tolerated device, which enables to conduct a comfortable continuous insulin infusion. The patients, who comply with medical instruction and perform self-monitoring are fit for diabetes treatment with personal insulin pump. According to present recommendation, there is not necessary to hospitalize patients to initiate continuous insulin infusion. Treatment with personal insulin pump takes up in Poland only in wards of Diabetology and Diabetes outpatient clinics. The main indications of personal insulin pump use are: unstable course of diabetes despite of the another intensive insulin methods used before, often hypoglycemic episodes in anamnesis, active, changing patient's life-style. Little daily insulin requirement < 20 U.l./24 hours, pregnancy. The essential advantages in personal insulin pump use are: prompt metabolic control improvement, a considerable liberty in meal consumption (in its time and amount) and intensity of effort, decrease in number of hypoglycemia and exactly insulin dosage establishment.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...